A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 5820-5827

  Gao, Qi ^a   Jiang, Yang ^a   Ma, Tian ^a   Zhu, Faliang ^a   Gao, Fei ^b   Zhang, Pin ^a   Guo, Chun ^a   Wang, Qun ^a   Wang, Xiaoyan ^a   Ma, Chunhong ^a   Zhang, Yun ^b   Chen, Wanjun ^c   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 17; NEUTRALIZING ANTIBODY; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL FUNCTION; CONTROLLED STUDY; DISEASE COURSE; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH17 CELLS;

EID: 78650637747     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000116     Document Type: Article

References (41)

1. Tedgui, A., and Z. Mallat. 2006. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86:515-581.
2. Weber, C., A. Zernecke, and P. Libby. 2008. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8:802-815.
3. Zhou, X., A. Nicoletti, R. Elhage, and G. K. Hansson. 2000. Transfer of CD4 (+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102:2919-2922.
4. Zhou, X., A. K. Robertson, C. Hjerpe, and G. K. Hansson. 2006. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26:864-870.
5. Buono, C., C. E. Come, G. Stavrakis, G. F. Maguire, P. W. Connelly, and A. H. Lichtman. 2003. Influence of interferon-gamma on the extent and phe-notype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arte-rioscler. Thromb. Vasc. Biol. 23:454-460.
6. Gupta, S., A. M. Pablo, X. Jiang, N. Wang, A. R. Tall, and C. Schindler. 1997. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99:2752-2761.
7. -/- mice. Am. J. Pathol. 157:1819-1824.
8. Lee, T. S., H. C. Yen, C. C. Pan, and L. Y. Chau. 1999. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19:734-742.
9. Davenport, P., and P. G. Tipping. 2003. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163:1117-1125.
10. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P. Holmes. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57:65-73.
11. Huber, S. A., P. Sakkinen, C. David, M. K. Newell, and R. P. Tracy. 2001. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103:2610-2616.
12. -/- mice. Arterioscler. Thromb. Vasc. Biol. 22:456-461.
13. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458.
14. Mills, K. H. 2004. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 4:841-855.
15. Aarvak, T., M. Chabaud, P. Miossec, and J. B. Natvig. 1999. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162:1246-1251.
16. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
17. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
18. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
19. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
20. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T (H) 17 lineage. Nature 441:231-234.
21. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-1133.
22. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
23. Koenders, M. I., E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M. M. Helsen, J. K. Kolls, L. A. Joosten, and W. B. van den Berg. 2005. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 52:975-983.
24. Eid, R. E., D. A. Rao, J. Zhou, S. F. Lo, H. Ranjbaran, A. Gallo, S. I. Sokol, S. Pfau, J. S. Pober, and G. Tellides. 2009. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119:1424-1432.
25. Cheng, X., X. Yu, Y. J. Ding, Q. Q. Fu, J. J. Xie, T. T. Tang, R. Yao, Y. Chen, and Y. H. Liao. 2008. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 127:89-97.
26. -/- mice. Cytokine 49:185-193.
27. Erbel, C., L. Chen, F. Bea, S. Wangler, S. Celik, F. Lasitschka, Y. Wang, D. Böckler, H. A. Katus, and T. J. Dengler. 2009. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J. Immunol. 183:8167-8175.
28. Taleb, S., M. Romain, B. Ramkhelawon, C. Uyttenhove, G. Pasterkamp, O. Herbin, B. Esposito, N. Perez, H. Yasukawa, J. Van Snick, et al. 2009. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 206:2067-2077.
29. von der Thüsen, J. H., T. J. van Berkel, and E. A. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103:1164-1170.
30. Ni, M., M. Zhang, S. F. Ding, W. Q. Chen, and Y. Zhang. 2008. Micro-ultrasound imaging assessment of carotid plaque characteristics in apolipoprotein-E knockout mice. Atherosclerosis 197:64-71.
31. Lusis, A. J. 2000. Atherosclerosis. Nature 407:233-241.
32. Glass, C. K., and J. L. Witztum. 2001. Atherosclerosis. the road ahead. Cell 104:503-516.
33. Smith, J. D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92:8264-8268.
34. Gimbrone, M. A., Jr. 1999. Vascular endothelium, hemodynamic forces, and atherogenesis. Am. J. Pathol. 155:1-5.
35. Gerhard, G. T., and P. B. Duell. 1999. Homocysteine and atherosclerosis. Curr. Opin. Lipidol. 10:417-428.
36. Reardon, C. A., L. Blachowicz, T. White, V. Cabana, Y. Wang, J. Lukens, J. Bluestone, and G. S. Getz. 2001. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:1011-1016.
37. Niwa, T., H. Wada, H. Ohashi, N. Iwamoto, H. Ohta, H. Kirii, H. Fujii, K. Saito, and M. Seishima. 2004. Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient mice. J. Atheroscler. Thromb. 11:79-87.
38. Ferretti, S., O. Bonneau, G. R. Dubois, C. E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170:2106-2112.
39. Jain, R., D. M. Tartar, R. K. Gregg, R. D. Divekar, J. J. Bell, H. H. Lee, P. Yu, J. S. Ellis, C. M. Hoeman, C. L. Franklin, and H. Zaghouani. 2008. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 205:207-218.
40. Irmler, I. M., M. Gajda, and R. Bräuer. 2007. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 179:6228-6236.
41. Zelante, T., A. De Luca, P. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti, M. L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695-2706.